Key result
A somatic nonsense DMD mutation (p.Arg2098X) caused severe dilated cardiomyopathy in a 26-year-old male, with skeletal muscle symptoms likely mitigated by genetic normalization.
Case Report (n=1)
Somatic DMD mutations should be considered in patients presenting with idiopathic dilated cardiomyopathy, as genetic normalization may mask skeletal muscle symptoms.
Somatic DMD mutations may underlie idiopathic DCM without skeletal signs; single-case evidence leaves open prevalence and screening utility.
Juan‐Mateu J, Paradas C, Olivé M, Verdura E, Rivas E, González‐Quereda L, Rodríguez MJ, Baiget M, Gallano P. Isolated cardiomyopathy caused by a DMD nonsense mutation in somatic mosaicism: genetic normalization in skeletal muscle. X‐linked dilated cardiomyopathy is a pure cardiac dystrophinopathy phenotype mainly caused by DMD mutations that present a specific transcription effect in cardiac tissue. We report a 26‐year‐old male who presented with severe dilated cardiomyopathy and high creatine kinase. The patient did not complain of skeletal muscle weakness. A muscle biopsy showed mild dystrophic changes and a low proportion of dystrophin‐negative fibres. A molecular study identified a nonsense DMD mutation (p.Arg2098X) in somatic mosaicism. The ratio of mutant versus normal allele in blood and skeletal muscle suggests selective pressure against mutant muscle cells, a process known as genetic normalization. We hypothesize that this process may have mitigated skeletal muscle symptoms in this patient. This is the second report of a DMD somatic mosaic with evidence of genetic normalization in muscle. Somatic DMD mutations should be considered in patients presenting with idiopathic dilated cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
Juan‐Mateu et al. (2011) conducted a case report in Severe dilated cardiomyopathy (n=1). DMD nonsense mutation (p.Arg2098X) in somatic mosaicism was evaluated on Genetic normalization in skeletal muscle. A somatic nonsense DMD mutation (p.Arg2098X) caused severe dilated cardiomyopathy in a 26-year-old male, with skeletal muscle symptoms likely mitigated by genetic normalization.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: